Related Posts

• 
  C-Path, CHDI Foundation, and CDISC Announce Public Review Period for Huntington’s Disease Therapeutic Area User Guide
• 
  National MS Society-Supported Collaborators Publish Reviews of Tools Used to Measure MS Progression
• 
  The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
• 
  Dopamine transporter neuroimaging as an enrichment biomarker in early Parkinson’s disease clinical trials: a disease progression modeling analysis
• 
  Advancing CDISC Standards for Biosensors Assessments in Clinical Drug Trials: 2017 Biometric Monitoring Device Workshop